×

Fixed dosing of HER antibodies

DC CAFC
  • US 7,449,184 B2
  • Filed: 06/15/2005
  • Issued: 11/11/2008
  • Est. Priority Date: 01/21/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating HER2 expressing cancer comprising administering one or more fixed dose(s) of HER2 antibody to a human patient in an amount effective to treat the cancer, wherein the fixed dose is selected from the group consisting of approximately 420 mg, approximately 525 mg, approximately 840 mg, and approximately 1050 mg of the HER2 antibody, wherein the HER2 antibody comprises the variable light and variable heavy amino acid sequences in SEQ ID Nos. 3 and 4, respectively.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×